Skip to content
Nonprofiteer
← PEDIATRIC CANCER RESEARCH FOUNDATION

Form 990 for tax year 2024

Filed by PEDIATRIC CANCER RESEARCH FOUNDATION.

This return was superseded by a later amendment. matched by us It is kept because history is preserved rather than replaced.

What the amendment changed

Compared with the latest return for 2024 , filed 18 March 2026. matched by us Only the Part I totals and the names listed in Part VII are compared. We relate returns by organization, tax year and form, and order them by each return's own timestamp; the filer's own "amended return" checkbox is a separate fact.

Total revenue
$1,384,349 changed to $4,224,824
Total expenses
$1,912,526 changed to $3,730,243
Contributions and grants received
$1,686,095 changed to $4,883,196
Grants paid
$914,813 changed to $1,695,918
Program services expenses
$1,193,411 changed to $2,261,147
Management and general expenses
$80,416 changed to $229,524
Fundraising expenses
$638,699 changed to $1,239,572
Program service expenses (Part III)
$1,193,411 changed to $2,261,147

Listed only on the earlier return

  • JERI WILSON
  • THOMAS BRENNAN

Listed only on the later return

  • BONNIE LATTIMORE
  • JERI WILLSON
  • LEN SHULMAN
  • MORGAN MARCH
  • SAVANNAH SCHMIER

Listed under a different title

  • DANIELLE FRAGALLA: CEO (AS OF 03/2024) then CEO

Totals

Total revenue
$1,384,349
Total expenses
$1,912,526
Contributions and grants received
$1,686,095
Grants paid
$914,813
Program services expenses (Part IX)
$1,193,411
Management and general expenses
$80,416
Fundraising expenses
$638,699
Program service expenses (Part III)
$1,193,411

Program services were 62.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Listed in Part VII

  • STEVE GIUSTO

    PRESIDENT

    Total calculated
    $0
    Hours/week
    1
  • JOHN COON

    VICE PRESIDENT

    Total calculated
    $0
    Hours/week
    1
  • THOMAS BRENNAN

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • BETH ABRAMS

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • SUSIE BUCHAN

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • TIM CROMWELL

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • CHERIE DALY

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • SCOTT ECKER

    TREASURER

    Total calculated
    $0
    Hours/week
    1
  • KEITH KOELLER

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • ELIZABETH MCNULTY

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • JASON O'DONNELL

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • AMANDA SARATSIS MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • JOHN VALLELY

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • DARTH VAUGHN

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • JOHN WEINER

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • NICOLE WILKINS

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • JERI WILSON

    EXECUTIVE DIRECTOR

    Total calculated
    $0
    Hours/week
    40
  • DANIELLE FRAGALLA

    CEO (AS OF 03/2024)

    Total calculated
    $0
    Hours/week
    40

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

  • PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE

  • TOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS

  • TARGETING SHP2 AS A THERAPEUTIC STRATEGY IN FUSION-NEGATIVE RHABDOMYOSARCOMA

  • TARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML

  • SINGLE-CELL DISSECTING OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

  • PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA

  • REWARDING PEDIATRIC PATIENTS AND ELEVATING THEIR CARE

  • UCSF

    $40,000

    TACL2020-004: A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA

  • PRECLINIAL STUDY TO TRANSLATE THERAPY USING DNA HYPOMETHYLATING AGENTS FOR PEDIATRIC HIGH GRADE GLIOMAS

  • USE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS

The 10 largest by cash amount. The API serves every itemized grant.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Provenance

Return type
form_990
Tax year
2024
Filed
2 April 2025
IRS schema version
2024v5.1
Source object
202521079349301112

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.